Patent Settlements Blocking Authorized Generics May Get Supreme Court Review

GlaxoSmithKline and Teva hope that lower court disagreements, if not exactly a circuit split, will be enough to get high court to revisit its Actavis decision.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America